Actavis PLC (NYSE: ACT)

Article Index

Actavis to Buy Forest Labs (NYSE: FRX) in $25 Billion Blockbuster Deal

best biotech investments 2014

Last week's $45.2 billion Time Warner-Comcast deal pushed the global deal tally to $336 billion so far this year - the most since 2007 - and another blockbuster deal announced this week will push that figure even higher.

On Tuesday Irish drugmaker Actavis PLC (NYSE: ACT), producer of generic and specialty urology and women's health products, agreed to buy New York-based Forest Laboratories Inc. (NYSE: FRX) for $25 billion.

To continue reading, please click here...